[276 Pages Report] The global competent cells market is expected to reach US$ 2.1 Billion by the end of 2022, registering double-digit growth at 11.1% CAGR during the forecast period (2022 to 2032). Sales in the market are expected to reach a valuation of ~US$ 5.9 Billion by 2032. In terms of product type, chemically competent cells led the market with a share of about 67.8% in 2021.
Competent cells are bacterial cells that can utilize foreign DNA from their surroundings through a process known as transformation. Griffith described it initially in Streptococcus pneumoniae. If the cell walls of E. coli are changed, the cells tend to absorb the DNA. Calcium chloride and temperature shock therapy can make the cells competent. Rapidly growing cells can be rendered more competent than cells at other phases of development.
Attributes
Key Insights
Competent Cells Market Value 2021
US$ 1.9 Billion
Estimated Market Size 2022
US$ 2.1 Billion
Projected Market Value 2032
US$ 5.9 Billion
CAGR 2022 to 2032
11.1%
Market Share of Top 5 Countries
57.4%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Cloning Applications to open up New Avenues during the Forecast Period
Cloning is expected to expand significantly in the application area due to the growing demand for molecularly cloned items. The cloning sector has benefited from COVID-19 as a result of corporations investing more money in research and development. Furthermore, it is anticipated that the segment would develop faster because of increased cloning research and financial assistance from a number of organizations.
Techniques for cell engineering, such as somatic cell nuclear transfer (SCNT), have demonstrated a variety of uses, including the creation of transgenic animals, the preservation of endangered species, and therapeutic cloning. Since competent cells may be employed in therapeutic cloning research, these fields are anticipated to experience renewed attention, which will lead to an increase in demand for these cells.
Due to rising Research and Development expenditures and the commercialization of proteomics and genomics-based goods, the biotechnology sector is also anticipated to see a significant growth rate. The need for cutting-edge product advancements in the treatment of different ailments is also anticipated to support the segment's expansion. Additionally, it is projected that increased investment in research into DNA cloning methods at academic research facilities and the usage of these products in therapies will accelerate market growth in the near future.
APAC to bring in more demand during 2022 to 2032
During the projected period, it is predicted that the Asia-Pacific market would account for a large portion of the worldwide competent cells market. Extensive research on DNA cloning methods in the area and the existence of significant market participants are credited with the expansion. For instance, Takara Bio Inc. stated in January 2021 that its new facility, the Center for Gene and Cell Processing II, for manufacturing and research purposes, had been completed in Shiga, Japan.
China is expected to develop at a profitable CAGR of 10.1% throughout the projected period and will hold a market share of around 54.2% in East Asia in 2021. The competent cells market will grow as research funding and activity increase. For instance, the State Key Laboratory of Microbial Application, the Natural Science Foundation of China, and SDU's Qilu Youth Scholar Start-up Funding all provided funding for a research study on Escherichia coli BW25113 competent cells made using a straightforward chemical method that has unparalleled transformation and cloning efficiencies in 2022.
Another regional company, HiMedia Solutions, is situated in India and produces a wide range of goods for the market for competent cells. The HiPurA BL21(DE3) Competent Cells, Bacterial Transformation Kit, HiPurA XL1-Blue Competent Cells, and HiPurA Competent Cells are its four main items for this market. The business is India's top producer of trustworthy cells. Its goods made cloning experiments simpler, such as the HiPurA Competent Cells, which were the first competent DH5a cells marketed on the Indian market. The existence of such businesses is probably going to benefit market growth.
Competent cells are bacterial cells, which can utilize foreign DNA from their surroundings through a process known as transformation. Griffith described it initially in Streptococcus pneumoniae. If the cell walls of E.coli are changed, the cells have a greater tendency to absorb the DNA. Calcium chloride and temperature shock therapy can make the cells competent. Rapidly growing cells can be rendered more competent than cells at other phases of development. Following transformation, the cells may express the acquired genetic information.
Find your sweet spots for generating winning opportunities in this market.
Sales Analysis of Competent Cells Market from 2017 to 2021 Vs Demand Outlook for 2022 to 2032
As per Future Market Insights (FMI), the competent cells market was approximately 12.8% of the overall ~US$ 14.5 Billion global cell expansion market in 2021. Overall sales of competent cells expanded at a CAGR of 9.9% from 2017 to 2021, on the back of the rising expansion of the healthcare industry.
Increasing adoption of molecular cloned products, recombinant proteins, advancement in molecular cloning research and development with the emergence of new technologies, and numerous government initiatives and government grants available for life science research are the key factors driving industry growth during the forecast period.
Gene therapy can potentially treat a wide range of ailments. The increasing prevalence of cancer, cardiovascular diseases, cystic fibrosis, blood disorders, and immunocompromised cases is rising, which will boost the market in the forecast period. Gene therapy attempts to cure an ailment or enhance your body's capacity to fight disease by replacing a malfunctioning gene or introducing a new gene.
According to World Health Organization (WHO) 2022, cancer is the largest cause of mortality around the globe, accounting for over 10 million deaths in 2020, or roughly one in every six. Colon, lung, breast, rectum, and prostate cancers are the most prevalent. Tobacco use, obesity, alcohol consumption, a lack of consumption of fruits and vegetables, and an insufficient level of physical activity account for almost one-third of cancer fatalities.
In addition, cystic fibrosis is a widespread hereditary condition throughout the white population in the USA. The condition affects one in every 2,500 to 3,500 white babies. Cystic fibrosis affects around one in every 17,000 African Americans and 31,000 Asian Americans, as stated by MedlinePlus in 2021. These conditions require gene therapy, which will positively impact the competent cells market. Backed by these aforementioned factors, the global competent cells market is expected to grow at a CAGR of 11.1% during the forecast period.
What are the Key Opportunities for the Competent Cells Market Manufacturers?
Favorable Government Initiatives for Gene Therapy Products to Push the Sales
Growth in the market is predicted to surge on the back of favourable initiatives by governments in emerging countries, increasing FDA approval for gene therapy products, and advancements in research and developmental activities. These factors will boost the demand for better technologies, creating a conducive environment in the competent cells market.
Recombinant DNA technology is one of the most commonly used techniques in introducing a specific gene or a healthy gene into a vector. These vectors can be plasmodial, viral, or nanostructured; the latter is the most commonly used because of its efficacy in colonizing cells and incorporating their genetic material.
Recent advances in recombinant DNA synthesis have enabled the effective production of recombinant proteins at industrial sizes with higher yields and lower production costs. This has enabled the development of new treatments, vaccines, and diagnostic reagents.
Certain nutrients are allowed to clone human genes, which reduces the likelihood of unfavourable immune system reactions in patients, allows for the creation of highly specialized, functional, and active proteins, increases productivity and cost-effectiveness, and reduces the possibility of unknown pathogen transmission from animals or humans.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
What are the Factors Restraining the Demand for Competent Cells?
The rising costs of research and developmental activities and stringent regulations in the field might hamper the growth in the forecast period. Competent cells are utilized in molecular cloning procedures, protein expression, and various plasmid DNA-based applications.
However, depending on the transformation method, for instance, developing the E. coli competent cells can be time-consuming, needing exceptionally pure water, high-grade reagents, specified autoclaved glassware, and or even specialized equipment (electroporators).
Numerous protocols available describe the technique and buffers needed to produce competent cells. There are even kits available that include pre-made buffers to expedite this process. Furthermore, it is more expensive to use electroporation.
A specialized apparatus is required to implement the charge, in addition to cuvettes to transport the charge to the cell solution. Excess salt in the cuvette can cause electroporation to fail and result in the loss of valuable samples. The most widely mentioned disadvantage of chemical transformation is its reduced efficiency.
Country-wise Insights
What Makes the USA a Lucrative Competent Cells Market?
Growing Investment in Gene Cell Therapy Products to Boost the Demand
The USA dominated the North American competent cells market and accounted for nearly 84.8% in 2021. Demand in the market is anticipated to surge on the back of rising investment in gene therapy products. Further, increasing research and development by government bodies, grants, and clinical trials for disease treatment and others, will improve the growth of the competent cells market.
Will China Retain its Dominance in the East Asia Competent Cells Market?
China Competent Cells Market to Benefit from Rising Research & Development for Cloning Efficiency
China held approximately 54.2% share in the East Asia competent cells market in 2021. Demand for competent cells in China will rise at a CAGR of 10.1% during the forecast period. Increasing research activities and grants will propel the competent cells market.
For instance, the Natural Science Foundation of China, the funding by the State Key Laboratory of Microbial Application, and the Qilu Youth Scholar Start-up Funding of SDU, funded a research study on Escherichia coli BW25113 competent cells prepared using a simple chemical method having unmatched transformation and cloning efficiencies, in 2022.
What is the Demand Outlook in Germany's Competent Cells Market?
Introduction of Different Strains for Gene Transformation to Propel Sales
As per FMI, the overall sales in the German competent cells market are projected to expand at 9.3% CAGR in the Europe competent cells market during the forecast period. Increasing production activities by manufacturers to develop different types of strains, which allows easy gene transformation, will propel the market. For instance, New England Biolabs GmbH has products specific to cloning & subcloning and strains for protein expression, with each type having quality specifications.
Category-wise Insights
Which Competent Cells Product is Driving Market Growth?
Nearly 7 out of 10 Sales to be Contributed by Chemically Competent Cells
Chemically competent cells are expected to present high growth at a CAGR of 15.3% between 2022 and 2032, with a share of about 67.8% in 2021. Cloning, DNA sequencing, and the creation of DNA libraries are just a few of the many molecular biology techniques that frequently include transformation. Competent cells must be used to perform the transformation. Chemically competent cells hold a bigger market share because chemical transformation is quicker and less error-prone than electroporation.
Which is the Chief Application in Competent Cells Market?
Cloning Segment to Account for Around 3/5th of Competent Cells Sales
In terms of application, the cloning segment held a revenue share of 57.8% in 2021 and is expected to display steady growth over the forecast period. Competent cells are frequently employed in molecular cloning to increase and preserve cloned DNA in plasmids because they are engineered to absorb foreign DNA from the environment more efficiently. With growing investments in cell and gene therapy, the cloning segment holds a higher market share in terms of application within the overall competent cells market, globally.
Based on end users, the academic research institutes held the highest market share value of 51.2% in 2021. Increasing research and development activities in life sciences are propelling sales of the overall competent cells market.
Competitive Landscape
With several competitors in the competent cells market, the overall market is fragmented. To expand their customer base, leading companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.
For instance:
The VmaxTM X2 Competent Cells were introduced in January 2020 by SGI-DNA, the company behind the BioXpTM 3200 System and Gibson Assembly® Reagents. They are intended to produce two to four times as much soluble protein in half the time as current methods that rely on E. coli.
Bluebird Bio announced the introduction of ZYNTEGLOTM Gene Therapy for Patients with Transfusion-Dependent -Thalassemia Who Do Not Have β?/β0 Genotype in Germany in January 2020.
Report Scope as per Competent Cells Industry Analysis
Attribute
Details
Estimated Market Size 2022
US$ 2.1 Billion
Projected Market Value 2032
US$ 5.9 Billion
CAGR 2022 to 2032
11.1%
Forecast Period
2017 to 2021
Historical Data Available for
2022 to 2032
Market Analysis
US$ Million for Value
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered
USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa
Key Market Segments Covered in Competent Cells Industry Research
By Product:
Chemically Competent Cells
Electrocompetent Cells
By Application:
Cloning
Protein Expression
Other Applications
By End User:
Academic Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Frequently Asked Questions
How much is the competent cells market worth in 2021?
The global competent cells market is worth US$ 1.9 Billion in 2021 and is set to expand by 2.9X over the next ten years.
What is the sales forecast for the competent cells market through 2032?
The competent cells market is expected to reach US$ 5.9 Billion by the end of 2032, with sales revenue expected to register an 11.1% CAGR.
What are the key trends shaping the competent cells industry?
The growing prevalence of genetic disorders and increasing research and developments are some of the key trends in this market.
Which are the top five countries driving demand for competent cells?
The USA, India, China, Germany, and Japan are expected to drive demand for the competent cells industry.
What is the North American market outlook for competent cells?
North America is expected to lead the growth in the competent cells market, with the USA accounting for about 84.8% of the share in 2021.
At what percentage is the demand for competent cells expected to increase in Europe?
Demand for competent cells in Europe is expected to register a growth of 10.9% over the next ten years.
What is the growth outlook of Latin America competent cells market over the forecast period?
Demand for competent cells in Latin America is expected to register a growth at 10.6% CAGR over the next ten years
At what percentage is the demand for competent cells expected to register growth in MEA?
Demand for competent cells in MEA is expected to register a growth of 8.7% over the next ten years
Which countries are the key producers of competent cells?
China, the USA, and Germany are the key producers of competent cells.
Table of Content
1. Executive Summary | Competent Cells Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology
4.2. Cost Structure
4.3. Regulatory Scenario
4.4. Reimbursement Landscape
4.5. PESTEL analysis
4.6. Porter’s analysis
4.7. Supply Chain
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare GDP Growth Overview
5.1.3. Global Cell Expansion Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising prevalence of Chronic Diseases
5.2.2. Increasing Awareness and Adoption
5.2.3. New Product Launches
5.2.4. Growing Research and Development for Competent Cells
5.2.5. Growing Investments for Molecular Cloning Research
5.2.6. Growing Commercial Demand for Molecular Cloned Products
5.3. Value Chain
5.3.1. Raw Material Suppliers
5.3.2. Product Manufacturers
5.3.3. End Users
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Opportunity Analysis
5.5. Global Supply Demand Analysis
6. COVID-19 Crisis - Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By End User
6.1.4. By Region
6.2. 2021 Market Scenario
7. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Product, 2017 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2022 to 2032
8.3.1. Chemically Competent Cells
8.3.2. Electrocompetent Cells
8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032
9.3.1. Cloning
9.3.2. Protein Expression
9.3.3. Other Applications
9.4. Market Attractiveness Analysis By Application
10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis, By End User, 2017 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032
10.3.1. Academic Research Institutes
10.3.2. Pharmaceutical & Biotechnology Companies
10.3.3. Contract Research Organizations
10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2021
11.3. Current Market and Future Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
12.3.1. By Country
12.3.1.1. United States of America
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Application
12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country-Level Analysis & Forecast
12.8.1. USA Market Analysis
12.8.1.1. .Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By Application
12.8.1.2.3. By End User
12.8.2. Canada Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By Application
12.8.2.2.3. By End User
13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2021
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Application
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country-Level Analysis & Forecast
13.8.1. Mexico Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Application
13.8.1.2.3. By End User
13.8.2. Brazil Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Application
13.8.2.2.3. By End User
13.8.3. Argentina Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By Application
13.8.3.2.3. By End User
14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2021
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. United Kingdom
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country-Level Analysis & Forecast
14.8.1. Germany Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application
14.8.1.2.3. By End User
14.8.2. Italy Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Application
14.8.2.2.3. By End User
14.8.3. France Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Application
14.8.3.2.3. By End User
14.8.4. UK Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Product
14.8.4.2.2. By Application
14.8.4.2.3. By End User
14.8.5. Spain Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast by Market Taxonomy
14.8.5.2.1. By Product
14.8.5.2.2. By Application
14.8.5.2.3. By End User
14.8.6. BENELUX Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast by Market Taxonomy
14.8.6.2.1. By Product
14.8.6.2.2. By Application
14.8.6.2.3. By End User
14.8.7. Russia Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast by Market Taxonomy
14.8.7.2.1. By Product
14.8.7.2.2. By Application
14.8.7.2.3. By End User
15. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2021
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Malaysia
15.3.1.4. Thailand
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. India Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. Indonesia Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.2.2.3. By End User
15.8.3. Malaysia Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application
15.8.3.2.3. By End User
15.8.4. Thailand Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Application
15.8.4.2.3. By End User
16. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2021
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. China Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Japan Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. By End User
16.8.3. South Korea Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application
16.8.3.2.3. By End User
17. Oceania Market 2017 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2021
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country-Level Analysis & Forecast
17.7.1. Australia Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Product
17.7.1.2.2. By Application
17.7.1.2.3. By End User
17.7.2. New Zealand Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Product
17.7.2.2.2. By Application
17.7.2.2.3. By End User
18. Middle East and Africa (MEA) Market Analysis 2017 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2021
18.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country-Level Analysis & Forecast
18.8.1. GCC Countries Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. Turkey Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application
18.8.2.2.3. By End User
18.8.3. South Africa Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Application
18.8.3.2.3. By End User
18.8.4. North Africa Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Application
18.8.4.2.3. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Agilent Technologies Inc.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Profitability by Market Segments (Product/Channel/Region)
20.3.1.4. Sales Footprint
20.3.1.5. SWOT Analysis
20.3.1.6. Key Financials
20.3.1.7. Strategy Overview
20.3.2. Genescript Biotech Corporation
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Profitability by Market Segments (Product/Channel/Region)
20.3.2.4. Sales Footprint
20.3.2.5. SWOT Analysis
20.3.2.6. Key Financials
20.3.2.7. Strategy Overview
20.3.3. Bio-Rad Laboratories Inc
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Profitability by Market Segments (Product/Channel/Region)
20.3.3.4. Sales Footprint
20.3.3.5. SWOT Analysis
20.3.3.6. Key Financials
20.3.3.7. Strategy Overview
20.3.4. Merck & Co Inc
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Profitability by Market Segments (Product/Channel/Region)
20.3.4.4. Sales Footprint
20.3.4.5. SWOT Analysis
20.3.4.6. Key Financials
20.3.4.7. Strategy Overview
20.3.5. OriGene Technologies, Inc
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Profitability by Market Segments (Product/Channel/Region)
20.3.5.4. Sales Footprint
20.3.5.5. SWOT Analysis
20.3.5.6. Key Financials
20.3.5.7. Strategy Overview
20.3.6. New England Biolabs Inc
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Profitability by Market Segments (Product/Channel/Region)
20.3.6.4. Sales Footprint
20.3.6.5. SWOT Analysis
20.3.6.6. Key Financials
20.3.6.7. Strategy Overview
20.3.7. Illumina, Inc.
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Profitability by Market Segments (Product/Channel/Region)
20.3.7.4. Sales Footprint
20.3.7.5. SWOT Analysis
20.3.7.6. Key Financials
20.3.7.7. Strategy Overview
20.3.8. Thermo Fisher Scientific, Inc.,
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Profitability by Market Segments (Product/Channel/Region)
20.3.8.4. Sales Footprint
20.3.8.5. SWOT Analysis
20.3.8.6. Key Financials
20.3.8.7. Strategy Overview
20.3.9. QIAGEN N.V.,
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Profitability by Market Segments (Product/Channel/Region)
20.3.9.4. Sales Footprint
20.3.9.5. SWOT Analysis
20.3.9.6. Key Financials
20.3.9.7. Strategy Overview
20.3.10. Zymo Research Corporation
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Profitability by Market Segments (Product/Channel/Region)
20.3.10.4. Sales Footprint
20.3.10.5. SWOT Analysis
20.3.10.6. Key Financials
20.3.10.7. Strategy Overview
20.3.11. Promega Corporation
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Profitability by Market Segments (Product/Channel/Region)
20.3.11.4. Sales Footprint
20.3.11.5. SWOT Analysis
20.3.11.6. Key Financials
20.3.11.7. Strategy Overview
20.3.12. HiMedia Laboratories
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Profitability by Market Segments (Product/Channel/Region)
20.3.12.4. Sales Footprint
20.3.12.5. SWOT Analysis
20.3.12.6. Key Financials
20.3.12.7. Strategy Overview
20.3.13. Avantor, Inc.
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Profitability by Market Segments (Product/Channel/Region)
20.3.13.4. Sales Footprint
20.3.13.5. SWOT Analysis
20.3.13.6. Key Financials
20.3.13.7. Strategy Overview
20.3.14. Scarab Genomics, LLC
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Profitability by Market Segments (Product/Channel/Region)
20.3.14.4. Sales Footprint
20.3.14.5. SWOT Analysis
20.3.14.6. Key Financials
20.3.14.7. Strategy Overview
20.3.15. Lucigen
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Profitability by Market Segments (Product/Channel/Region)
20.3.15.4. Sales Footprint
20.3.15.5. SWOT Analysis
20.3.15.6. Key Financials
20.3.15.7. Strategy Overview
20.3.16. Tonbo Biosciences
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Profitability by Market Segments (Product/Channel/Region)
20.3.16.4. Sales Footprint
20.3.16.5. SWOT Analysis
20.3.16.6. Key Financials
20.3.16.7. Strategy Overview
20.3.17. Transgen Biotech
20.3.17.1. Overview
20.3.17.2. Product Portfolio
20.3.17.3. Profitability by Market Segments (Product/Channel/Region)
20.3.17.4. Sales Footprint
20.3.17.5. SWOT Analysis
20.3.17.6. Key Financials
20.3.17.7. Strategy Overview
20.3.18. Codex DNA, Inc.
20.3.18.1. Overview
20.3.18.2. Product Portfolio
20.3.18.3. Profitability by Market Segments (Product/Channel/Region)
20.3.18.4. Sales Footprint
20.3.18.5. SWOT Analysis
20.3.18.6. Key Financials
20.3.18.7. Strategy Overview
20.3.19. bluebird bio, Inc.
20.3.19.1. Overview
20.3.19.2. Product Portfolio
20.3.19.3. Profitability by Market Segments (Product/Channel/Region)
20.3.19.4. Sales Footprint
20.3.19.5. SWOT Analysis
20.3.19.6. Key Financials
20.3.19.7. Strategy Overview
21. Assumptions and Acronyms Used22. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 02: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032by Application
Table 03: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 04: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region
Table 05: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 06: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 07: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 08: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 09: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 10: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 11: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 12: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 13: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 14: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 15: Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032by Application
Table 16: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 17: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 18: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 19: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 20: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 21: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 22: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 23: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 24: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 25: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 26: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 27: Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032 by Application
Table 28: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 29: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 30: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 31: Middle East & Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032by Application
Table 32: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Market Value (US$ Million) Analysis, 2017 to 2021
Figure 02: ;Global Market Forecast & Y-o-Y Growth, 2022 to 2032
Figure 03: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022 to 2032
Figure 04: Global Market Value Share (%) Analysis 2022 and 2032, by Product
Figure 05: Global Market Y-o-Y Growth (%) Analysis 2022 to 2032, by Product
Figure 06: Global Market Attractiveness Analysis 2022 to 2032, by Product
Figure 07: Global Market Value Share (%) Analysis 2022 and 2032, by Application
Figure 08: Global Market Y-o-Y Growth (%) Analysis 2022 to 2032, by Application
Figure 09: Global Market Attractiveness Analysis 2022 to 2032, by Application
Figure 10: Global Market Value Share (%) Analysis 2022 and 2032, by End User
Figure 11: Global Market Y-o-Y Growth (%) Analysis 2022 to 2032, by End User
Figure 12: Global Market Attractiveness Analysis 2022 to 2032, by End User
Figure 13: Global Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 14: Global Market Y-o-Y Growth (%) Analysis 2022 to 2032, by Region
Figure 15: Global Market Attractiveness Analysis 2022 to 2032, by Region
Figure 16: North America Market Value (US$ Million) Analysis, 2017 to 2021
Figure 17: North America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 18: North America Market Value Share, by Product (2022 E)
Figure 19: North America Market Value Share, by Application (2022 E)
Figure 20: North America Market Value Share, by End User (2022 E)
Figure 21: North America Market Value Share, by Country (2022 E)
Figure 22: North America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 23: North America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 24: North America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 25: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 26: USA Market Value Proportion Analysis, 2021
Figure 27: Global Vs USA Growth Comparison
Figure 28: USA Market Share Analysis (%) by Product, 2021 to 2032
Figure 29: USA Market Share Analysis (%) by Application, 2021 to 2032
Figure 30: USA Market Share Analysis (%) by End User, 2021 to 2032
Figure 31: Canada Market Value Proportion Analysis, 2021
Figure 32: Global Vs. Canada. Growth Comparison
Figure 33: Canada Market Share Analysis (%) by Product, 2021 to 2032
Figure 34: Canada Market Share Analysis (%) by Application, 2021 to 2032
Figure 35: Canada Market Share Analysis (%) by End User, 2021 to 2032
Figure 36: Latin America Market Value (US$ Million) Analysis, 2017 to 2021
Figure 37: Latin America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 38: Latin America Market Value Share, by Product (2022 E)
Figure 39: Latin America Market Value Share, by Application (2022 E)
Figure 40: Latin America Market Value Share, by End User (2022 E)
Figure 41: Latin America Market Value Share, by Country (2022 E)
Figure 42: Latin America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 43: Latin America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 44: Latin America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 45: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 46: Mexico Market Value Proportion Analysis, 2021
Figure 47: Global Vs Mexico Growth Comparison
Figure 48: Mexico Market Share Analysis (%) by Product, 2021 to 2032
Figure 49: Mexico Market Share Analysis (%) by Application, 2021 to 2032
Figure 50: Mexico Market Share Analysis (%) by End User, 2021 to 2032
Figure 51: Brazil Market Value Proportion Analysis, 2021
Figure 52: Global Vs. Brazil. Growth Comparison
Figure 53: Brazil Market Share Analysis (%) by Product, 2021 to 2032
Figure 54: Brazil Market Share Analysis (%) by Application, 2021 to 2032
Figure 55: Brazil Market Share Analysis (%) by End User, 2021 to 2032
Figure 56: Argentina Market Value Proportion Analysis, 2021
Figure 57: Global Vs Argentina Growth Comparison
Figure 58: Argentina Market Share Analysis (%) by Product, 2021 to 2032
Figure 59: Argentina Market Share Analysis (%) by Application, 2021 to 2032
Figure 60: Argentina Market Share Analysis (%) by End User, 2021 to 2032
Figure 61: Europe Market Value (US$ Million) Analysis, 2017 to 2021
Figure 62: Europe Market Value (US$ Million) Forecast, 2022 to 2032
Figure 63: Europe Market Value Share, by Product (2022 E)
Figure 64: Europe Market Value Share, by Application (2022 E)
Figure 65: Europe Market Value Share, by End User (2022 E)
Figure 66: Europe Market Value Share, by Country (2022 E)
Figure 67: Europe Market Attractiveness Analysis by Product, 2022 to 2032
Figure 68: Europe Market Attractiveness Analysis by Application, 2022 to 2032
Figure 69: Europe Market Attractiveness Analysis by End User, 2022 to 2032
Figure 70: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 71: UK Market Value Proportion Analysis, 2021
Figure 72: Global Vs. UK Growth Comparison
Figure 73: UK Market Share Analysis (%) by Product, 2021 to 2032
Figure 74: UK Market Share Analysis (%) by Application, 2021 to 2032
Figure 75: UK Market Share Analysis (%) by End User, 2021 to 2032
Figure 76: Germany Market Value Proportion Analysis, 2021
Figure 77: Global Vs. Germany Growth Comparison
Figure 78: Germany Market Share Analysis (%) by Product, 2021 to 2032
Figure 79: Germany Market Share Analysis (%) by Application, 2021 to 2032
Figure 80: Germany Market Share Analysis (%) by End User, 2021 to 2032
Figure 81: Italy Market Value Proportion Analysis, 2021
Figure 82: Global Vs. Italy Growth Comparison
Figure 83: Italy Market Share Analysis (%) by Product, 2021 to 2032
Figure 84: Italy Market Share Analysis (%) by Application, 2021 to 2032
Figure 85: Italy Market Share Analysis (%) by End User, 2021 to 2032
Figure 86: France Market Value Proportion Analysis, 2021
Figure 87: Global Vs France Growth Comparison
Figure 88: France Market Share Analysis (%) by Product, 2021 to 2032
Figure 89: France Market Share Analysis (%) by Application, 2021 to 2032
Figure 90: France Market Share Analysis (%) by End User, 2021 to 2032
Figure 91: Spain Market Value Proportion Analysis, 2021
Figure 92: Global Vs Spain Growth Comparison
Figure 93: Spain Market Share Analysis (%) by Product, 2021 to 2032
Figure 94: Spain Market Share Analysis (%) by Application, 2021 to 2032
Figure 95: Spain Market Share Analysis (%) by End User, 2021 to 2032
Figure 96: Russia Market Value Proportion Analysis, 2021
Figure 97: Global Vs Russia Growth Comparison
Figure 98: Russia Market Share Analysis (%) by Product, 2021 to 2032
Figure 99: Russia Market Share Analysis (%) by Application, 2021 to 2032
Figure 100: Russia Market Share Analysis (%) by End User, 2021 to 2032
Figure 101: BENELUX Market Value Proportion Analysis, 2021
Figure 102: Global Vs BENELUX Growth Comparison
Figure 103: BENELUX Market Share Analysis (%) by Product, 2021 to 2032
Figure 104: BENELUX Market Share Analysis (%) by Application, 2021 to 2032
Figure 105: BENELUX Market Share Analysis (%) by End User, 2021 to 2032
Figure 106: East Asia Market Value (US$ Million) Analysis, 2017 to 2021
Figure 107: East Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 108: East Asia Market Value Share, by Product (2022 E)
Figure 109: East Asia Market Value Share, by Application (2022 E)
Figure 110: East Asia Market Value Share, by End User (2022 E)
Figure 111: East Asia Market Value Share, by Country (2022 E)
Figure 112: East Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 113: East Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 114: East Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 115: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 116: China Market Value Proportion Analysis, 2021
Figure 117: Global Vs. China Growth Comparison
Figure 118: China Market Share Analysis (%) by Product, 2021 to 2032
Figure 119: China Market Share Analysis (%) by Application, 2021 to 2032
Figure 120: China Market Share Analysis (%) by End User, 2021 to 2032
Figure 121: Japan Market Value Proportion Analysis, 2021
Figure 122: Global Vs. Japan Growth Comparison
Figure 123: Japan Market Share Analysis (%) by Product, 2021 to 2032
Figure 124: Japan Market Share Analysis (%) by Application, 2021 to 2032
Figure 125: Japan Market Share Analysis (%) by End User, 2021 to 2032
Figure 126: South Korea Market Value Proportion Analysis, 2021
Figure 127: Global Vs South Korea Growth Comparison
Figure 128: South Korea Market Share Analysis (%) by Product, 2021 to 2032
Figure 129: South Korea Market Share Analysis (%) by Application, 2021 to 2032
Figure 130: South Korea Market Share Analysis (%) by End User, 2021 to 2032
Figure 131: South Asia Market Value (US$ Million) Analysis, 2017 to 2021
Figure 132: South Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 133: South Asia Market Value Share, by Product (2022 E)
Figure 134: South Asia Market Value Share, by Application (2022 E)
Figure 135: South Asia Market Value Share, by End User (2022 E)
Figure 136: South Asia Market Value Share, by Country (2022 E)
Figure 137: South Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 138: South Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 139: South Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 140: South Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 141: India Market Value Proportion Analysis, 2021
Figure 142: Global Vs. India Growth Comparison
Figure 143: India Market Share Analysis (%) by Product, 2021 to 2032
Figure 144: India Market Share Analysis (%) by Application, 2021 to 2032
Figure 145: India Market Share Analysis (%) by End User, 2021 to 2032
Figure 146: Indonesia Market Value Proportion Analysis, 2021
Figure 147: Global Vs. Indonesia Growth Comparison
Figure 148: Indonesia Market Share Analysis (%) by Product, 2021 to 2032
Figure 149: Indonesia Market Share Analysis (%) by Application, 2021 to 2032
Figure 150: Indonesia Market Share Analysis (%) by End User, 2021 to 2032
Figure 151: Malaysia Market Value Proportion Analysis, 2021
Figure 152: Global Vs. Malaysia Growth Comparison
Figure 153: Malaysia Market Share Analysis (%) by Product, 2021 to 2032
Figure 154: Malaysia Market Share Analysis (%) by Application, 2021 to 2032
Figure 155: Malaysia Market Share Analysis (%) by End User, 2021 to 2032
Figure 156: Thailand Market Value Proportion Analysis, 2021
Figure 157: Global Vs. Thailand Growth Comparison
Figure 158: Thailand Market Share Analysis (%) by Product, 2021 to 2032
Figure 159: Thailand Market Share Analysis (%) by Application, 2021 to 2032
Figure 160: Thailand Market Share Analysis (%) by End User, 2021 to 2032
Figure 161: Oceania Market Value (US$ Million) Analysis, 2017 to 2021
Figure 162: Oceania Market Value (US$ Million) Forecast, 2022 to 2032
Figure 163: Oceania Market Value Share, by Product (2022 E)
Figure 164: Oceania Market Value Share, by Application (2022 E)
Figure 165: Oceania Market Value Share, by End User (2022 E)
Figure 166: Oceania Market Value Share, by Country (2022 E)
Figure 167: Oceania Market Attractiveness Analysis by Product, 2022 to 2032
Figure 168: Oceania Market Attractiveness Analysis by Application, 2022 to 2032
Figure 169: Oceania Market Attractiveness Analysis by End User, 2022 to 2032
Figure 170: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 171: Australia Market Value Proportion Analysis, 2021
Figure 172: Global Vs. Australia Growth Comparison
Figure 173: Australia Market Share Analysis (%) by Product, 2021 to 2032
Figure 174: Australia Market Share Analysis (%) by Application, 2021 to 2032
Figure 175: Australia Market Share Analysis (%) by End User, 2021 to 2032
Figure 176: New Zealand Market Value Proportion Analysis, 2021
Figure 177: Global Vs New Zealand Growth Comparison
Figure 178: New Zealand Market Share Analysis (%) by Product, 2021 to 2032
Figure 179: New Zealand Market Share Analysis (%) by Application, 2021 to 2032
Figure 180: New Zealand Market Share Analysis (%) by End User, 2021 to 2032
Figure 181: Middle East & Africa Market Value (US$ Million) Analysis, 2017 to 2021
Figure 182: Middle East & Africa Market Value (US$ Million) Forecast, 2022 to 2032
Figure 183: Middle East & Africa Market Value Share, by Product (2022 E)
Figure 184: Middle East & Africa Market Value Share, by Application (2022 E)
Figure 185: Middle East & Africa Market Value Share, by End User (2022 E)
Figure 186: Middle East & Africa Market Value Share, by Country (2022 E)
Figure 187: Middle East & Africa Market Attractiveness Analysis by Product, 2022 to 2032
Figure 188: Middle East & Africa Market Attractiveness Analysis by Application, 2022 to 2032
Figure 189: Middle East & Africa Market Attractiveness Analysis by End User, 2022 to 2032
Figure 190: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2032
Figure 191: GCC Countries Market Value Proportion Analysis, 2021
Figure 192: Global Vs GCC Countries Growth Comparison
Figure 193: GCC Countries Market Share Analysis (%) by Product, 2021 to 2032
Figure 194: GCC Countries Market Share Analysis (%) by Application, 2021 to 2032
Figure 195: GCC Countries Market Share Analysis (%) by End User, 2021 to 2032
Figure 196: Turkey Market Value Proportion Analysis, 2021
Figure 197: Global Vs. Turkey Growth Comparison
Figure 198: Turkey Market Share Analysis (%) by Product, 2021 to 2032
Figure 199: Turkey Market Share Analysis (%) by Application, 2021 to 2032
Figure 200: Turkey Market Share Analysis (%) by End User, 2021 to 2032
Figure 201: South Africa Market Value Proportion Analysis, 2021
Figure 202: Global Vs. South Africa Growth Comparison
Figure 203: South Africa Market Share Analysis (%) by Product, 2021 to 2032
Figure 204: South Africa Market Share Analysis (%) by Application, 2021 to 2032
Figure 205: South Africa Market Share Analysis (%) by End User, 2021 to 2032
Figure 206: North Africa Market Value Proportion Analysis, 2021
Figure 207: Global Vs North Africa Growth Comparison
Figure 208: North Africa Market Share Analysis (%) by Product, 2021 to 2032
Figure 209: North Africa Market Share Analysis (%) by Application, 2021 to 2032
Figure 210: North Africa Market Share Analysis (%) by End User, 2021 to 2032
